(Public, NYSE:STE)   Watch this stock  
Find more results for Richard Shine�
-0.23 (-0.46%)
Apr 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 49.38 - 50.07
52 week 39.90 - 51.87
Open 49.97
Vol / Avg. 251,698.00/253,417.00
Mkt cap 2.94B
P/E 22.50
Div/yield 0.21/1.69
EPS 2.21
Shares 58.91M
Beta 1.01
Inst. own 92%
May 5, 2014
Q4 2014 STERIS Corporation Earnings Release (Estimated) Add to calendar
Mar 5, 2014
STERIS Corporation at Raymond James Financial Inc Institutional Investors Conference - Webcast
Feb 24, 2014
STERIS Corporation at Citi Global Healthcare Conference
Feb 5, 2014
Q3 2014 STERIS Corporation Earnings Conference Call - Webcast
Feb 5, 2014
Q3 2014 STERIS Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 7.03% 10.65%
Operating margin 13.78% 16.17%
EBITD margin - 20.70%
Return on average assets 6.41% 10.10%
Return on average equity 11.45% 18.11%
Employees 6,000 -
CDP Score - -


5960 Heisley Road
MENTOR, OH 44060
United States - Map
+1-440-3542600 (Phone)
+1-440-6394457 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


STERIS Corporation is a provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and research. The Company offers its Customers a mix of capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room (OR) integration; consumable products, such as detergents and skin care products, gastrointestinal (GI) endoscopy accessories, and other products; services, including equipment installation and maintenance; and microbial reduction of medical devices, instrument and scope repair solutions, and laboratory testing services. The Company operates in three reportable business segments: Healthcare, Life Sciences and STERIS Isomedix Services. In March 2014, Steris Corp acquired Eschmann Holdings Ltd, a Lancing-based manufacturer and wholesaler of medical equipments, from SISK Group.

Officers and directors

John P. Wareham Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Walter M. Rosebrough Jr. President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Michael J. Tokich Chief Financial Officer, Senior Vice President
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter A. Burke Chief Technology Officer, Senior Vice President
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark D. McGinley Senior Vice President, General Counsel, Secretary
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David Allen Johnson Senior Vice President - Global Operations and Quality
Age: 51
Bio & Compensation  - Reuters
Robert E. Moss Senior Vice President, Group President - STERIS Isomedix Services and Life Sciences
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William L. Aamoth Vice President, Corporate Treasurer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Suzanne V. Forsythe Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
Richard C. Breeden Independent Director
Age: 64
Bio & Compensation  - Reuters